Stay updated with breaking news from Parul Kodan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two doses of Covaxin are 50 per cent effective against symptomatic Covid-19, according to the first real-world assessment of India's indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.
The odds of vaccination with Covaxin were compared between cases and controls and adjusted for occupational exposure to COVID-19, previous SARS-CoV-2 infection, and infection dates.
Two doses of Covaxin are 50 per cent effective against the Delta variant of coronavirus disease, according to the first real-world assessment of India's indigenous Covid-19 vaccine published in The Lancet Infectious Diseases journal.
Two doses of Covaxin have shown 50 per cent effectiveness against symptomatic disease, according to the first real-world assessment of India's indigenous COVID-19 vaccine.
Two doses of Covaxin are 50 per cent effective against symptomatic disease, according to the first real-world assessment of India's indigenous COVID-19 vaccine published in The Lancet Infectious Diseases journal.